Dupilumab-associated head and neck dermatitis resolves temporarily with itraconazole therapy and rapidly with transition to upadacitinib, with Malassezia-specific immunoglobulin E levels mirroring clinical response
Emily Kozera, Akshay Flora, T. D. Stewart, Kyra Gill, Jennifer Xu, Mae Anne De La Vega, John W. Frew
Topics & Concepts
DupilumabMedicineDermatologyMalasseziaAtopic dermatitisImmunoglobulin EErythemaBiomarkerSensitizationImmunologyAntibodyChemistryBiochemistryDermatology and Skin DiseasesNail Diseases and TreatmentsContact Dermatitis and Allergies